IRCT20150101020514N29尚未招募2 期
Evaluating the safety and efficacy of MBI X-Mild dermal filler (Mizan Behdasht CO.) for correction of moderate to severe nasolabial folds
Mizan Behdasht Company0 个研究点目标入组 30 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 65 years（—）
- 性别
- All
入选标准
- •18-65 year old men and women
- •Moderate to severe nasolabial folds based on Allergan criteria
- •The opportunity to accompany the visit programs and study process
- •Signing the informed consent form and agree to a 6-month follow-up
排除标准
- •Previous hyaluronic acid (HA)-based dermal filler treatment(s) injected within the last 12 months prior to enrollment.
- •Cosmetic facial procedures (chemical peel, laser, radio frequency, dermabrasion, ablative or non-ablative procedures), Botox) in the lower 2/3 of the face, within 3 months prior to study entry
- •Planning to undergo any of these procedures at any time during the study
- •Auto immune or immune deficiency diseases
- •Allergy to gram positive bacteria protein, gel ingredients
- •Pregnancy and Lactation
研究者
相似试验
已完成
不适用
Evaluation of the efficacy and safety of the MYNX CONTROL™ vascular closure device for achieving primary haemostasis after arterial femoral access following peripheral arterial interventions compared to the FemoSealTM vascular closure deviceI70.22DRKS00031251niversitäts-Herzzentrum Campus Bad Krozingen - Uniklinikum Freiburg273
已完成
不适用
Clinical study on the safety and efficacy of medium-chain fatty acid capsules (CNT-02) for primary triglyceride deposit cardiomyovasculopathy (TGCV) and neutral lipid storage disease with myopathy (NLSD-M)Primary triglyceride deposit cardiomyovasculopathy (TGCV) Neutral lipid storage disease with myopathy (NLSD-M)JPRN-UMIN000023043Translational Research Informatics Center, Foundation for Biomedical Research and Innovation10
招募中
2 期
Evaluation of safety and the effectiveness of Bioba (Prime) anti-hair loss line (serum and shampoo)IRCT20190210042676N16Akhavi laboratory19
招募中
不适用
Evaluation of Effectiveness and Safety of BioMimeTM stent in the Korean Patients with Acute Coronary Syndrome; Multicenter, Prospective, Observational Clinical TrialKCT0003025Chonnam National University Hospital2,000
已完成
4 期
Biomodulina T - IM- covid-19 - older adultos - Phase IV clinical trialPrevention of infections, including covid-19Covid-19SARS-CoV2Disease PreventionAgingCoronavirus InfectionsSARS VirusCoronaviridae InfectionsBetacoronavirusRPCEC00000310Centro Nacional de Biopreparados (BioCen)